Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Mã chứng khoánCDXS
Tên công tyCodexis Inc
Ngày IPOApr 22, 2010
Giám đốc điều hànhDr. Stephen G. Dilly, Ph.D.
Số lượng nhân viên188
Loại chứng khoánOrdinary Share
Kết thúc năm tài chínhApr 22
Địa chỉ200 Penobscot Dr
Thành phốREDWOOD CITY
Sàn giao dịch chứng khoánNASDAQ Global Select Consolidated
Quốc giaUnited States of America
Mã bưu điện94063
Điện thoại16504218100
Trang webhttps://www.codexis.com/
Mã chứng khoánCDXS
Ngày IPOApr 22, 2010
Giám đốc điều hànhDr. Stephen G. Dilly, Ph.D.
Tổng cộng
0.00
USD đã được phân phối dưới dạng cổ tức trong 5 năm qua.

Không có dữ liệu